Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
- Conditions
- Interventions
- First Posted Date
- 2018-01-19
- Last Posted Date
- 2020-06-29
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 501
- Registration Number
- NCT03405064
- Locations
- 🇮🇳
Government Medical College, Kozhikode, Kerala, India
🇮🇳LTM Medical College and General Hospital, Mumbai, Maharashtra, India
🇮🇳Oyster & Pearl Hospital, Pune, Maharashtra, India
To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment
- First Posted Date
- 2016-10-24
- Last Posted Date
- 2018-08-02
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 48
- Registration Number
- NCT02942810
- Locations
- 🇺🇸
University of Miami,Division of Clinical Pharmacology, Miami, Florida, United States
Phase II Study of Oral Nafithromycin in CABP
- Conditions
- Interventions
- First Posted Date
- 2016-09-16
- Last Posted Date
- 2019-12-20
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 231
- Registration Number
- NCT02903836
- Locations
- 🇺🇸
Health Concepts, Bedford, South Dakota, United States
🇺🇸A & L Clinical research, Miami, Florida, United States
🇺🇸A Plus Research Inc., Miami, Florida, United States
A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects
- First Posted Date
- 2016-05-12
- Last Posted Date
- 2018-08-01
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 60
- Registration Number
- NCT02770404
- Locations
- 🇺🇸
Phase 1 unit : Spaulding Clinical Research, LLC, West Bend, Wisconsin, United States
A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal Impairment
- First Posted Date
- 2016-03-16
- Last Posted Date
- 2016-08-26
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 48
- Registration Number
- NCT02709382
- Locations
- 🇺🇸
University of Miami,Division of Clinical Pharmacology, Miami, Florida, United States
MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2016-03-14
- Last Posted Date
- 2016-08-04
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 20
- Registration Number
- NCT02707107
- Locations
- 🇺🇸
Quintiles, Overland Park, Kansas, United States
MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults
- First Posted Date
- 2016-02-04
- Last Posted Date
- 2016-08-04
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 21
- Registration Number
- NCT02674347
- Locations
- 🇺🇸
Quintiles, Overland Park, Kansas, United States
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime
- Conditions
- Interventions
- First Posted Date
- 2015-08-25
- Last Posted Date
- 2016-05-03
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 88
- Registration Number
- NCT02532140
- Locations
- 🇺🇸
Quintiles, Overland Park, Kansas, United States
Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects
- First Posted Date
- 2015-05-25
- Last Posted Date
- 2015-08-03
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 36
- Registration Number
- NCT02453529
- Locations
- 🇺🇸
Pulmonary Associates, 1112 E. McDowell Rd., Phoenix, Arizona, United States
Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects
- First Posted Date
- 2014-10-01
- Last Posted Date
- 2015-10-29
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 30
- Registration Number
- NCT02253342
- Locations
- 🇺🇸
Pulmonary Associates, 1112 E. McDowell Rd., Phoenix, Arizona, United States